Preimplantation genetic testing for sickle cell disease: a cost-effectiveness analysis.

Joshua C Combs,Maura Dougherty,Meghan U Yamasaki,Alan H DeCherney,Kate M Devine,Micah J Hill,Erin Rothwell,Jeanne E O'Brien,Richard E Nelson

F&S reports（2023）

引用 0|浏览2

暂无评分

摘要

Our model demonstrates that IVF + PGT-M for selection against SCD, compared with lifetime SOC treatment for those affected, is the most cost-effective strategy within the United States healthcare sector.

查看译文

关键词

Cost,sickle cell disease,PGT-M

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要